Filing Details
- Accession Number:
- 0001209191-19-056527
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-14 14:16:05
- Reporting Period:
- 2019-11-12
- Accepted Time:
- 2019-11-14 14:16:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1563577 | Galera Therapeutics Inc. | GRTX | () | G7 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1388325 | A/S Holdings Novo | Tuborg Havnevej 19 Hellerup G7 2900 | No | No | Yes | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-12 | 2,373,152 | $0.00 | 2,373,152 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2019-11-12 | 535,869 | $0.00 | 2,909,021 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2019-11-12 | 500,000 | $12.00 | 3,409,021 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | SERIES B PREFERRED STOCK | Disposition | 2019-11-12 | 12,000,000 | $0.00 | 2,373,152 | $0.00 |
| Common Stock | SERIES C PREFERRED STOCK | Disposition | 2019-11-12 | 2,709,659 | $0.00 | 535,869 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering, in accordance with the applicable conversion ratio, resulting in the acquisition of the number of shares of Common Stock shown. There was no expiration date for the preferred stock.
- Represents a purchase from the underwriters in the Issuer's public offering.
Billionaire Hedge Funds
